Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29453034 | 0.98 | RECQL (0.53) | RECQLPOLBGAAALDH1A1EZH2 | |
| Sulfuric Acid SCHEMBL986271 | 0.92 | RECQL (0.49) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL6109968 | 0.89 | RECQL (0.46) | RECQLPOLBGAAALDH1A1EZH2 | |
| Nitrilotriacetic Acid SCHEMBL986939 | 0.85 | GAA (0.48) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL10525290 | 0.84 | RECQL (0.57) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL3295977 | 0.84 | RECQL (0.57) | RECQLPOLBGAAALDH1A1EZH2 | |
| SCHEMBL28402532 | 0.83 | POLB (0.57) | RECQLPOLBGAAALDH1A1EZH2 | |
| Edetic Acid SCHEMBL986441 | 0.82 | GAA (0.46) | RECQLPOLBGAAEZH2HTT | |
| SCHEMBL9420237 | 0.81 | GAA (0.48) | RECQLPOLBGAAALDH1A1EZH2 | |
| Pentetic Acid SCHEMBL985300 | 0.81 | GAA (0.45) | RECQLPOLBGAAEZH2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705508-A1 | METHODS FOR ANALYSIS OF DNA METHYLATION | Guardant Health, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| CN-115838938-B | Method for preparing 19-formyl-4-androstene-3, 17-dione by electrocatalytic oxidation of carbon volcano-like catalyst | 浙江工业大学 | 2025-05-13 | — | — | CN | claimed |
| WO-2024229433-A1 | METHODS FOR ANALYSIS OF DNA METHYLATION | GUARDANT HEALTH, INC. (US) | 2024-11-07 | — | — | WO | claimed |
| EP-4036074-A1 | METHOD FOR SUPPRESSING THE POLYMERIZATION OF UNSATURATED AROMATIC MONOMERS | Evonik Operations GmbH (DE) | 2022-08-03 | — | — | EP | claimed |
| US-10721907-B2 | Antimicrobial compositions and methods with novel polymeric binding system | OXISCIENCE, LLC (US) | 2020-07-28 | — | — | US | claimed |
| US-20180325076-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS WITH NOVEL POLYMERIC BINDING SYSTEM | OXISCIENCE, LLC (US) | 2018-11-15 | — | — | US | claimed |
| US-10028482-B2 | Disinfecting and deodorizing compositions and methods with novel polymeric binding system | OXISCIENCE LLC (US) | 2018-07-24 | — | — | US | claimed |
| EP-3186333-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS WITH NOVEL POLYMERIC BINDING SYSTEM | Cao, Zhengbing (US) | 2017-07-05 | — | — | EP | claimed |
| EP-2055691-B1 | Method for stabilising olefinically unsaturated monomers | EVONIK DEGUSSA GMBH (DE) | 2016-08-31 | — | — | EP | claimed |
| US-20160058008-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS WITH NOVEL POLYMERIC BINDING SYSTEM | OXISCIENCE WA, LLC | 2016-03-03 | — | — | US | claimed |
| WO-2016033340-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS WITH NOVEL POLYMERIC BINDING SYSTEM | CAO ZHENGBING (US) | 2016-03-03 | — | — | WO | claimed |
| US-8128804-B2 | Process for stabilizing olefinically unsaturated monomers | EVONIK DEGUSSA GMBH (DE) | 2012-03-06 | — | — | US | claimed |
| US-20090114878-A1 | PROCESS FOR STABILIZING OLEFINICALLY UNSATURATED MONOMERS | EVONIK DEGUSSA GMBH (DE) | 2009-05-07 | — | — | US | claimed |
| US-5670685-A | Process for preparing carboxylates of polyoxyalkylene siloxanes | CLARIANT FINANCE (BVI) LIMITED (VG) | 1997-09-23 | — | — | US | claimed |
| US-5668261-A | Process for preparing carboxylates of alkylpolyglucosides | CLARIANT FINANCE (BVI) LIMITED (VI) | 1997-09-16 | — | — | US | claimed |
| US-5504246-A | Process for preparing carboxylates of alkylpolyoxyalkylenes | SANDOZ LTD. (CH) | 1996-04-02 | — | — | US | claimed |
| JP-10139744-A | — | — | None | — | — | JP | disclosed |
| JP-5255544-A | — | — | None | — | — | JP | disclosed |
| EP-0389419-A1 | Non-migrating 1-hydrocarbyloxy hindered amine compounds as polymer stabilizers | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
| EP-0389421-A1 | Poly(1-hydrocarbyloxy-2,2,6,6-tetraalkylpiperidine) light stabilizers | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10028482-B2 | Disinfecting and deodorizing compositions and methods with novel polymeric binding system | LPO, CUTA, DDO | RECQL 3326/4885POLB 421/4885GAA 869/4885 |
| US-20180325076-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS WITH NOVEL POLYMERIC BINDING SYSTEM | LPO, CUTA, MPO | RECQL 3852/4885POLB 217/4885GAA 524/4885 |
| US-20160058008-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS WITH NOVEL POLYMERIC BINDING SYSTEM | LPO, CUTA, MPO | RECQL 3852/4885POLB 217/4885GAA 524/4885 |
| US-10721907-B2 | Antimicrobial compositions and methods with novel polymeric binding system | LPO, CUTA, MPO | RECQL 3852/4885POLB 217/4885GAA 524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.